Research Paper Volume 16, Issue 5 pp 4736—4758
Investigating the mechanisms of drug resistance and prognosis in ovarian cancer using single-cell RNA sequencing and bulk RNA sequencing
Figure 5. Subgroup analysis of EPCs and related data. (A) Heatmap showing CNV status of subgroup cells. (B) UNMP distribution of subgroup cells. (C) Expression patterns of the top 5 signature genes in each subgroup. (D) UNMP distribution of drug responses in subgroup cells. (E) Proportion of subgroup cells within the Resistant, Refractory, and Sensitive response groups. (F) Proportion of subgroup cells within the Resistant, Refractory, and Sensitive response groups and their facets were shown. (G) UNMP distribution of cell staging in subgroup cells. (H) Proportion of subgroup cells within the G2M, S, and G1 cell staging phases. (I) Proportion of subgroup cells within the G2M, S, and G1 cell staging phases and their facets were shown. (J) UNMP distribution of G2M.Score. (K, L) Abundance of subgroup cells concerning drug response groups and cell staging. (M–O) UNMP distribution of S.Score, nFeature, and nCount.